摘要
目的 分析平阳霉素联合地塞米松治疗儿童颌面部血管瘤的效果。方法 对126例颌面部血管瘤患者分别采用平阳霉素联合地塞米松治疗（观察组）74例,平阳霉素治疗（对照组）52例,观察两组治疗效果和不良反应。结果 观察组痊愈率为85.13％,对照组痊愈率为34.61％,两组差异有统计学意义（P〈0.05）;两组患者不良反应发生率,差异无统计学意义（P〉0.05）。结论 平阳霉素联合地塞米松注射治疗儿童颌面部血管瘤,其疗效确切,操作简单,值得向临床广泛推荐和应用。
Objective To analyze and summarize the effects of pingyangmycin （PYM） combined with dexamethasone in the treatment of children with oral and maxillofacial hemangioma.Methods Clinical data of 126 patients with maxillofacial hemangioma were retrospectively analyzed.74 patients were treated with PYM combined with dexamethasone（observation group）,52 patients were treated with PYM（control group）.The therapeutic effects and adverse reactions were observed in two groups.Results After treatment,the cure rate of observation group was 85.13%,which was higher than control group（34.61%）,and the difference was statistically significant（P〈0.05）.The incidence rate of adverse reactions of the two groups was similar,and the difference was not statistically significant（P〉0.05）.Conclusion PYM combined with dexamethasone in the treatment of children with maxillofacial hemangioma has good efficacy and low incidence rate of adverse reactions,and it is worth widely recommended and applied in clinic.
出处
《中国基层医药》
CAS
2013年第9期1349-1350,I0001,共3页
Chinese Journal of Primary Medicine and Pharmacy
关键词
血管瘤
儿童
面部
Hemangioma
Child
Face
